@article{052c3ad6eb1944f696a52af7ab0dcf68,
title = "Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial (Annals of Hematology, (2021), 100, 5, (1181-1194), 10.1007/s00277-021-04465-4)",
abstract = "A correction to this paper has been published: https://doi.org/10.1007/s00277-021-04545-5.",
author = "Michael Heuser and Smith, {B. Douglas} and Walter Fiedler and Sekeres, {Mikkael A.} and Pau Montesinos and Brian Leber and Akil Merchant and Cristina Papayannidis and P{\'e}rez-Sim{\'o}n, {Jos{\'e} A.} and Hoang, {Caroline J.} and Thomas O{\textquoteright}Brien and Ma, {Weidong Wendy} and Mirjana Zeremski and Ashleigh O{\textquoteright}Connell and Geoffrey Chan and Cortes, {Jorge E.}",
note = "Publisher Copyright: {\textcopyright} 2021, Springer-Verlag GmbH Germany, part of Springer Nature.",
year = "2021",
month = jul,
doi = "10.1007/s00277-021-04545-5",
language = "English (US)",
volume = "100",
pages = "1917--1918",
journal = "Annals of Hematology",
issn = "0939-5555",
publisher = "Springer Verlag",
number = "7",
}